Robert Olstein Olstein Capital Management
Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$3.92M |
| 2 |
SOLS
Solstice Advanced Materials
SOLS
|
+$2.72M |
| 3 |
Uber
UBER
|
+$1.62M |
| 4 |
Mohawk Industries
MHK
|
+$1.52M |
| 5 |
Baxter International
BAX
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$7.63M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$7.48M |
| 3 |
Comcast
CMCSA
|
+$5.25M |
| 4 |
Kimberly-Clark
KMB
|
+$4.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$3.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.54% |
| 2 | Technology | 18.02% |
| 3 | Healthcare | 15.69% |
| 4 | Financials | 14.91% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Walt Disney
DIS
$186B
| $12.3M | 2.52% |
107,864
-1,136
| -1% | -$125K |
|
2
LKQ Corp
LKQ
$6.52B
| $9.61M | 1.97% |
318,266
| – | – |
|
3
Vontier
VNT
$4.46B
| $9.52M | 1.95% |
256,000
| – | – |
|
4
Sensata Technologies
ST
$6.23B
| $9.45M | 1.94% |
284,000
-62,000
| -18% | -$1.98M |
|
5
Avantor
AVTR
$9.78B
| $9.37M | 1.92% |
818,000
+24,000
| +3% | +$295K |
|
6
ABM Industries
ABM
$2.74B
| $8.94M | 1.83% |
211,361
+2,389
| +1% | +$105K |
|
7
Omnicom Group
OMC
$24B
| $8.88M | 1.82% |
110,000
| – | – |
|
8
International Flavors & Fragrances
IFF
$21.5B
| $8.56M | 1.76% |
127,000
+2,000
| +2% | +$129K |
|
9
SLB Ltd
SLB
$79.9B
| $8.44M | 1.73% |
220,000
-33,000
| -13% | -$1.2M |
|
10
Becton Dickinson
BDX
$52.3B
| $8.25M | 1.69% |
42,500
-9,500
| -18% | -$1.81M |
|
11
Fidelity National Information Services
FIS
$21.3B
| $8.07M | 1.66% |
121,470
+8,470
| +7% | +$558K |
|
12
Target
TGT
$75.1B
| $8.02M | 1.64% |
82,000
| – | – |
|
|
13
Baxter International
BAX
$13.6B
| $7.97M | 1.63% |
417,000
+52,000
| +14% | +$1.04M |
|
|
14
Mohawk Industries
MHK
$9.23B
| $7.51M | 1.54% |
68,750
+13,250
| +24% | +$1.52M |
|
15
Nasdaq
NDAQ
$54.9B
| $7.51M | 1.54% |
77,300
-3,700
| -5% | -$333K |
|
16
General Dynamics
GD
$104B
| $7.41M | 1.52% |
22,000
-1,290
| -6% | -$440K |
|
17
Zimmer Biomet
ZBH
$19.3B
| $7.37M | 1.51% |
82,000
+4,000
| +5% | +$379K |
|
18
FedEx
FDX
$76.9B
| $7.37M | 1.51% |
25,500
-6,500
| -20% | -$1.71M |
|
19
Dine Brands
DIN
$454M
| $7.36M | 1.51% |
229,000
-81,711
| -26% | -$2.37M |
|
|
RAL
20
Ralliant Corp
RAL
$7.04B
| $7.28M | 1.49% |
143,000
-2,000
| -1% | -$93.7K |
|
21
Middleby
MIDD
$5.22B
| $7.14M | 1.46% |
48,000
-9,000
| -16% | -$1.18M |
|
22
Delta Air Lines
DAL
$54.2B
| $7.09M | 1.45% |
102,100
-31,900
| -24% | -$1.99M |
|
23
Medtronic
MDT
$119B
| $7.01M | 1.44% |
73,000
-14,000
| -16% | -$1.36M |
|
24
Travelers Companies
TRV
$75.8B
| $6.96M | 1.43% |
24,000
| – | – |
|
25
Quest Diagnostics
DGX
$27B
| $6.94M | 1.42% |
40,000
| – | – |
|
Similar funds
Robert Olstein's Q4 2025 Portfolio in Review
As of Q4 2025, Robert Olstein held 105 positions worth $488M, down 7.9% from $530M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Robert Olstein withdrew a net $57.9M in Q4 2025, closing 4 positions and reducing 55 holdings. Its most notable exit was Hologic, an estimated $7.63M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Robert Olstein opened a new position in Lockheed Martin worth $3.97M.
- Robert Olstein's largest Q4 2025 buy was Lockheed Martin: 8,200 shares worth $3.97M.
- Robert Olstein added most to Uber in Q4 2025, an estimated $1.62M increase.
- Robert Olstein's biggest Q4 2025 reduction was Johnson & Johnson, cutting an estimated $3.86M.
- Robert Olstein fully exited Hologic in Q4 2025, selling an estimated $7.63M.
- Robert Olstein's ten largest holdings make up 19% of its $488M portfolio in Q4 2025.
- Robert Olstein opened 2 new positions and closed 4 in Q4 2025.
- Robert Olstein's portfolio value fell 7.9% quarter-over-quarter to $488M.
Based on Olstein Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.